Biogen cuts annual profit forecast on higher deal costs (Nov 8)
(This Nov. 8 story has been corrected to say Biogen cut profit forecast due to costs related to a deal,
2023-11-15 07:57
Eisai expects Alzheimer's drug to rake in revenue of $66.5 million by March
Japanese drugmaker Eisai said on Tuesday it was targeting revenue of 10 billion yen ($66.5 million) from its
2023-11-07 22:18